Avi Weisfogel and the Fight for a Good Night’s Sleep

Getting your full eight to nine hours of sleep is not only something that your mother may have enforced on you as a small child, but also has real scientific benefits. Getting the recommended amount of sleep can help improve your skin, reduce hair loss, reduce stress and a variety of other wonderful benefits to your body and mind. Some adults attempt to get their full night’s sleep but are hindered by medical conditions like sleep apnea. Dr. Avi Weisfogel and his team hope to shed some light on this sleep thief.

Dr. Avi Weisfogel is a not a sleep doctor, but rather an accomplished dentist. He works with patients who have sleep apnea and has been designing oral devices that help sleep apnea sufferers get a better night’s sleep. He is hoping that with collaboration between the world of dentistry and sleep medicine, people suffering from sleep apnea and similar disorders can find the peace and much needed rest that they deserve.
Dr. Weisfogel holds a degree in psychology and biology from Rutger’s University in New Jersey. His DDS is from the College of Dentistry at New York University. His passion in dentistry and working with different professional groups have helped him gain a different perspective on dentistry and help him reach a wider audience for his sleep apnea work. His creation of the Dental Sleep Master’s Program will help countless professionals in dentistry, healthcare, and a variety of other professions reach people who could benefit from oral devices to help aid their symptoms of sleep apnea. His current focus is on the Dental Sleep Masters Program and teaching professionals around the world about the benefits of these oral devices.

How Mikhail Blagosklonny has Played a Major Role in Oncology and Cancer Research

Mikhail Blagosklonny is one of the renowned scientists in oncology and cancer research. Currently, he works as the professor of oncology at the popular Roswell Park Cancer Institute situated in New York. Mikhail’s research touches on various interests including cellular and molecular biology, as well as clinical investigations.

On a more specific level, Mikhail Blagosklonny specializes on cell cycle, signal transduction, tumor suppressors, anticancer therapeutics, mitosis and apoptosis. His research also extends to aging and other age-related illnesses. In this case, Mikhail looks at the underlying aspects or mechanism of aging.

Academic and Career Background

Blagosklonny backs up his roles as a professor and scientist with excellent academic records. He not only has an M.D in internal medicine but also holds a Ph.D. in cardiology and experimental medicine. Mikhail earned his Ph.D. from the First Pavlov State Medical University of St. Petersburg.

Mikhail embarked on his career in 2002 at the New York Medical College where he served in the capacity of an appointed associate professor. He then took up a position at Albany-based Ordway Research Institute as a senior scientist. Blagosklonny ended his tenure at Ordway Research after being appointed as the professor of oncology at the Roswell Park Cancer Institute.

Blogosklonny’s Hypothesis

In his research work, Blagosklonny is acknowledged for formulating a hypothesis regarding the possible function of TOR signaling in cancer and aging. Consequently, he suggested the use of a popular cancer treatment drug, rapamycin, as a possible cure for life extension. For this reason, he is considered by many as one of the enthusiastic proponents of using rapamycin in life extension research.

Read more: https://templeofthecave.com/mikhail-blagosklonny-a-review-of-his-life-achievements/

Editorial Work

As an author, Blagosklonny is known for coining with the hyper-function theory of aging and anti-cancer approaches called cyclotherapy and chemotherapeutic engineering. Over the years, he has taken part in the publication of about 300 research reviews, articles and book chapters. Mikhail Blagosklonny is the editor-in-chief and founding editor of Cell Cycle. He is also the co-founder and co-editor of Aging, Oncotarget and Oncoscience. Additionally, he serves as an associate editor of Cancer Biology & Therapy, International Journal of Cancer, PLOS ONE and Autophagy, Cancer Research, Cell Death and Differentiation. View Mikhail’s profile on Google Scholar

The Importance of Capital Anesthesiology Association

Capital Anesthesiology Association plays a vital role in the Austin, Texas Regional Area. This organization serves 20 medical facilities throughout the area with high quality anesthesiology care. Accidents happen all the time unfortunately, but CAA is there for each and every dire situation. Since 1973 the organization has grown dramatically and today it is the nation’s largest independent practice of specialized anesthesiology. Medical Facilities such as Seton Hayes, CAREOS, Texan Surgical Center, Dell Children’s Medical Center, Strictly Pediatrics, Hyde Park Surgery Center, and many more are being served around the clock.

This organization stands out from the rest because it covers such a large area, provides the very best care, and specializes in in pediatrics, obstetrics, and cardiothoracic anesthesiology. Patients need not to worry about billing and insurance issues as CAA’s administrative staff provides the best in handling all paperwork and documentation. Capital Anesthesiology Association covers all three areas of anesthesiology that pertain to Regional, General, and Local/MAC Anesthesiology. There isn’t anything CAA can’t do to make every patient feel as safe and secure as possible before, during, and after medical treatment.

Board Certified Physicians, Nurses, and Technicians grace the halls of this prominent institute on a daily basis. Capital Anesthesiology Association is setting new trends, raising the bar extremely high, and are changing the current status quo of anesthesiology services.

Check out more info about anesthesiology here: http://www.anesthesiologynews.com/Clinical-Anesthesiology/Article/01-17/Anesthesia-s-Cognitive-Effects-In-Young-Children-Vary-by-Age/38968